Editorial - (2025) Volume 11, Issue 3
Cancer has long been one of the most formidable challenges in medicine, often evading traditional treatments and returning with renewed aggression. But in recent years, a revolutionary approach has emerged—immunotherapy, and more specifically, checkpoint inhibitors. These drugs don’t attack cancer cells directly. Instead, they empower the body’s own immune system to do what it was designed to do: recognize and destroy threats.
Abstract
Cancer has long been one of the most formidable challenges in medicine, often evading traditional treatments and returning with renewed aggression. But in recent years, a revolutionary approach has emerged—immunotherapy, and more specifically, checkpoint inhibitors. These drugs don’t attack cancer cells directly. Instead, they empower the body’s own immune system to do what it was designed to do: recognize and destroy threats.
Published: 26-Sep-2025, DOI: 10.35248/2471-8556.25.11(3).012
Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.